[go: up one dir, main page]

MXPA04002474A - Inhibition of exoprotein production using aromatic compositions. - Google Patents

Inhibition of exoprotein production using aromatic compositions.

Info

Publication number
MXPA04002474A
MXPA04002474A MXPA04002474A MXPA04002474A MXPA04002474A MX PA04002474 A MXPA04002474 A MX PA04002474A MX PA04002474 A MXPA04002474 A MX PA04002474A MX PA04002474 A MXPA04002474 A MX PA04002474A MX PA04002474 A MXPA04002474 A MX PA04002474A
Authority
MX
Mexico
Prior art keywords
unsaturated aliphatic
aliphatic hydrocarbyl
hydrocarbyl moiety
saturated
monovalent
Prior art date
Application number
MXPA04002474A
Other languages
Spanish (es)
Inventor
Ellen Syverson Rae
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,391 external-priority patent/US7022333B2/en
Priority claimed from US09/969,218 external-priority patent/US7026354B2/en
Priority claimed from US09/969,299 external-priority patent/US20030135173A1/en
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MXPA04002474A publication Critical patent/MXPA04002474A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

Absorbent and non-absorbent articles are disclosed. The articles include an effective amount of an aromatic inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The aromatic inhibitory compounds of the present invention have the general formula (I), wherein R1 is selected from the group consisting of H, (a), -OR5, -R6C(O)H, -R6OH, -R6COOH, -OR6OH, -OR6COOH, -C(O)NH2, formula (1) and NH2 and salts thereof; R5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R2, R3, and R4 are independently selected from the group consisting of H, OH, COOH, and -C(O)R9; R9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.
MXPA04002474A 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions. MXPA04002474A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/969,391 US7022333B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
US09/969,218 US7026354B2 (en) 2001-10-02 2001-10-02 Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
US09/969,299 US20030135173A1 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using aromatic compositions
PCT/US2002/028756 WO2003030953A1 (en) 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions

Publications (1)

Publication Number Publication Date
MXPA04002474A true MXPA04002474A (en) 2004-05-31

Family

ID=27420759

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002474A MXPA04002474A (en) 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions.

Country Status (9)

Country Link
EP (1) EP1432459A1 (en)
JP (1) JP2005523239A (en)
KR (1) KR100918887B1 (en)
AR (1) AR037505A1 (en)
AU (1) AU2002336472B2 (en)
BR (1) BR0212679A (en)
CA (1) CA2461291A1 (en)
MX (1) MXPA04002474A (en)
WO (1) WO2003030953A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (en) 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molecule for the functionalization of a carrier, binding of a radionuclide to the carrier and radionuclide generator for the production of the radionuclide and production method
JP2017536893A (en) * 2014-11-27 2017-12-14 イェディテペ・ウニヴェルシテシＹｅｄｉｔｅｐｅ Ｕｎｉｖｅｒｓｉｔｅｓｉ Antibacterial and antiviral hygiene products
SG11201903162VA (en) * 2016-10-09 2019-05-30 Shenzhen Eulikan Biotechnology Co Ltd Uses of bacteriostatic agent formula in preparing composition for vaginal use and composition for vaginal use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
IL55214A (en) * 1978-07-25 1981-07-31 Abic Ltd Antibacterial compositions containing trimethoprim and other ingredients
DE3204124A1 (en) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC TAMPONS WITH HIGH ACTIVE SUBSTANCE RELEASE
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
GB2186486B (en) * 1986-02-13 1989-11-08 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5476455A (en) * 1993-01-11 1995-12-19 Silber; Arthur L. Toxicity resistant tampon structure
DE4411664A1 (en) * 1994-04-05 1995-10-12 Beiersdorf Ag Novel deodorant and antimicrobial compositions for use in cosmetic or topical preparations
JPH07289575A (en) * 1994-04-27 1995-11-07 Okamoto Ind Inc Rerfume-added condom and method for adding perfume to condom
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
DE4434781A1 (en) * 1994-09-29 1996-04-04 Beiersdorf Ag Use of fatty acid esters to combat superinfections
ES2182993T3 (en) * 1995-06-07 2003-03-16 Kimberly Clark Co INHIBITION OF EXOPROTEINS IN ABSORBENT ARTICLES.
JPH09108257A (en) * 1995-10-23 1997-04-28 Shiyouichi Masugi Luminous cream and latex condom
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
AU4421697A (en) * 1996-09-19 1998-04-14 American Home Products Corporation Method of treating urinary incontinence
ATE308987T1 (en) * 1997-04-18 2005-11-15 Ganeden Biotech Inc SURFACE USE OF PROBIOTIC BACILLUS SPORES TO PREVENT OR CONTROL MICROBIAL INFECTIONS
KR20010013377A (en) * 1997-06-04 2001-02-26 데이비드 엠 모이어 Mild, leave-on antimicrobial compositions
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
DE69805208T2 (en) * 1998-01-28 2002-12-05 The Procter & Gamble Company, Cincinnati ANTIMICROBIAL HYDROGEL-FORMING ABSORBENT POLYMERS
CN1263464A (en) * 1998-04-11 2000-08-16 伊利卡帕·尤罗特拉皮西有限公司 Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
FR2777783A1 (en) * 1998-04-24 1999-10-29 Innothera Lab Sa Pharmaceutical composition for treatment of infectious vulvovaginitis and vaginosis
KR100563881B1 (en) * 1998-05-29 2006-03-28 킴벌리-클라크 월드와이드, 인크. Improved odor absorption by natural and synthetic polymers

Also Published As

Publication number Publication date
EP1432459A1 (en) 2004-06-30
AR037505A1 (en) 2004-11-17
KR20040044950A (en) 2004-05-31
CA2461291A1 (en) 2003-04-17
AU2002336472B2 (en) 2007-08-23
JP2005523239A (en) 2005-08-04
BR0212679A (en) 2005-04-12
WO2003030953A1 (en) 2003-04-17
KR100918887B1 (en) 2009-09-23

Similar Documents

Publication Publication Date Title
IL174664A0 (en) Optically active amino alcohol derivatives and processes for the preparation thereof
PT1254144E (en) NEW PHOSPHORUS COMPOUNDS
CA2260999A1 (en) Heterocyclic compounds, their production and use in tyrosine kinase inhibition
IT1314184B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF STRESS-OXIDATIVE CONDITIONS
AU4114601A (en) Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
GB0019359D0 (en) Novel guanidines
GB1392044A (en) Corrosion inhibiting composition
NZ518302A (en) Compositions for treating plant diseases containing phosphonate and phosphate salts
WO2008006718A3 (en) Synergistic anti-microbial mixtures of tropolone (derivatives) and selected compounds
WO1996040300A3 (en) Inhibition of exoprotein in absorbent article
NO982873L (en) 1-methylcarbapenem
TW200505438A (en) Method of treating cancer with azaspirane compositions
MXPA04002474A (en) Inhibition of exoprotein production using aromatic compositions.
DE60002558D1 (en) Derivatives of phosphonic acid to inhibit carboxypeptidase B
MY136694A (en) New thiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
MY103502A (en) Novel compounds
IL110828A (en) 10-BICYCLOHETEROALKYL OR ALKENYL-7-OXOPYRIDO £1, 2, 3-d, e| £1, 3, 4| BENZOXADIAZINE- 6-CARBOXYLIC ACID AND DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
WO2002002098A3 (en) Antibacterial method and composition with phenolic compounds
JO2289B1 (en) Prdruge to nmda receptor ligands
MXPA06000651A (en) Use of indazole derivatives for the treatment of neuropathic pain.
WO2006038980A3 (en) Non-absorbent and absorbent articles for inhibiting the production of exoproteins
MY139608A (en) Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
PH23966A (en) Imidazoquinozoline compounds as agent for treatment of nephritis
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions

Legal Events

Date Code Title Description
FG Grant or registration